Gene · 7517
Papers2,149
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,149
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response. | Cell Rep Med | 2022 | 35584624 | PubTator, text mining | PubMed |
| The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events. | Cancer Lett | 2022 | 35568265 | PubTator, text mining | PubMed |
| A Novel Attention-Mechanism Based Cox Survival Model by Exploiting Pan-Cancer Empirical Genomic Information. | Cells | 2022 | 35563727 | PubTator, text mining | PubMed |
| Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients. | Int J Mol Sci | 2022 | 35563100 | PubTator, text mining | PubMed |
| Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden. | J Natl Cancer Inst | 2022 | 35511172 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair. | Front Oncol | 2022 | 35463312 | PubTator, text mining | PubMed |
| Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. | Sci Rep | 2022 | 35459784 | PubTator, text mining | PubMed |
| Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification. | Cancer Res | 2022 | 35425960 | PubTator, text mining | PubMed |
| Hereditary Gynecologic Cancer Syndromes - A Narrative Review. | Onco Targets Ther | 2022 | 35422633 | PubTator, text mining | PubMed |
| Mechanisms of Chemotherapy-Induced Neurotoxicity. | Front Pharmacol | 2022 | 35418856 | PubTator, text mining | PubMed |
| Factors Affecting the Nuclei in Newborn and Children. | Int J Environ Res Public Health | 2022 | 35409906 | PubTator, text mining | PubMed |
| BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma. | Int J Mol Sci | 2022 | 35409110 | PubTator, text mining | PubMed |
| A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782). | Cancer Med | 2022 | 35396812 | PubTator, text mining | PubMed |
| Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity. | Radiol Oncol | 2022 | 35390246 | PubTator, text mining | PubMed |
| An introduction to male breast cancer for urologists: epidemiology, diagnosis, principles of treatment, and special situations. | Int Braz J Urol | 2022 | 35373955 | PubTator, text mining | PubMed |
| Solid Tumor Opioid Receptor Expression and Oncologic Outcomes: Analysis of the Cancer Genome Atlas and Genotype Tissue Expression Project. | Front Oncol | 2022 | 35359418 | PubTator, text mining | PubMed |
| Is There a Role for Epigenetic Therapies in Modulating DNA Damage Repair Pathways to Enhance Chemotherapy and Overcome Drug Resistance? | Cancers (Basel) | 2022 | 35326684 | PubTator, text mining | PubMed |
| Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer. | Int J Breast Cancer | 2022 | 35320970 | PubTator, text mining | PubMed |
Association of genetic polymorphisms in DNA repair genes ERCC2 Asp312Asn (rs1799793), ERCC2 Lys 751 Gln (rs13181), XRCC1 Arg399 Gln (rs25487) and XRCC3 Thr 241Met (rs861539) with the susceptibility of lung cancer in Saudi population. | Nucleosides Nucleotides Nucleic Acids | 2022 | 35319340 | PubTator, text mining | PubMed |
| Double heterozygous mutation in RAD50 and ATM genes in a Peruvian family with five cancer types: a case report. | Rev Fac Cien Med Univ Nac Cordoba | 2022 | 35312250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7517/papers?page=14